Alpha 2.0
Login Register
» Articles » PMID: 20131236

Should Antibodies to High-density Lipoprotein Cholesterol and Its Components Be Measured in All Systemic Lupus Erythematosus Patients to Predict Risk of Atherosclerosis?

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2010 Feb 5
PMID 20131236
Citations 6
Authors
Bevra H Hahn
Affiliations
Soon will be listed here.
Citing Articles

Lipid Metabolism Profiles in Rheumatic Diseases.

Chen W, Wang Q, Zhou B, Zhang L, Zhu H Front Pharmacol. 2021; 12:643520.

PMID: 33897433 PMC: 8064727. DOI: 10.3389/fphar.2021.643520.

Psoriasis-associated vascular disease: the role of HDL.

Paiva-Lopes M, Delgado Alves J J Biomed Sci. 2017; 24(1):73.

PMID: 28911329 PMC: 5598036. DOI: 10.1186/s12929-017-0382-4.

Anti-apolipoprotein A-I antibodies and paraoxonase 1 activity in Systemic Lupus Erythematosus.

Ahmed M, Elserougy E, Al-Gazzar I, Fikry I, Habib D, Younes K EXCLI J. 2015; 12:719-32.

PMID: 26622215 PMC: 4663653.

Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice.

Black L, Srivastava R, Schoeb T, Moore R, Barnes S, Kabarowski J J Immunol. 2015; 195(10):4685-98.

PMID: 26466956 PMC: 4637240. DOI: 10.4049/jimmunol.1500806.

Anti-apolipoprotein A-1 antibodies and carotid intima-media thickness in Egyptian women with systemic lupus erythematosus.

Radwan M, El-Lebedy D, Fouda R, Elsorougy E Clin Rheumatol. 2013; 33(4):493-8.

PMID: 24077952 DOI: 10.1007/s10067-013-2399-8.